OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS
| Status: | Recruiting |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 3/27/2019 |
| Start Date: | March 13, 2019 |
| End Date: | May 9, 2019 |
| Contact: | Pfizer CT.gov Call Center |
| Email: | ClinicalTrials.gov_Inquiries@pfizer.com |
| Phone: | 1-800-718-1021 |
A PHASE 1, OPEN LABEL, TWO-PERIOD, RANDOMIZED CROSSOVER STUDY TO COMPARE THE PHARMACOKINETICS OF TWO DIFFERENT FORMULATIONS OF PF-05221304 ADMINISTERED ORALLY TO HEALTHY ADULT SUBJECTS
The purpose of this study is to characterize the plasma pharmacokinetics of two formulations
of PF 05221304 in healthy adults.
of PF 05221304 in healthy adults.
Inclusion Criteria:
- Ages of 18 and 55 years old inclusive
- Body Mass Index (BMI) of >= 17.5 and <= 30.4 kg/m2
- Total body weight > 50 kg (110lb)
Exclusion Criteria:
- Evidence or history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurological,
allergic disease or clinical findings
We found this trial at
1
site
Click here to add this to my saved trials
